Stellaromics

Stellaromics is an early-stage private company developing the Pyxa platform, which it describes as the first automated 3D spatial multi-omics platform. The integrated system combines sample preparation, volumetric confocal imaging, and AI-driven data analysis to enable researchers to study thick tissue sections and model complex biology in its native 3D architecture. With a leadership team featuring veterans from genomics and instrumentation and scientific founders from Stanford and the Broad Institute, the company is targeting the rapidly growing spatial biology market with a differentiated, high-throughput solution.

Pyxa platform: an integrated system for automated 3D spatial multi-omics, combining sample preparation, volumetric confocal imaging, and AI-driven data analysis and visualization.

Stellaromics competes in the spatial biology market against dominant 2D players like 10x Genomics, NanoString, and Akoya Biosciences. Its primary differentiation is its automated, integrated workflow for 3D volumetric analysis, a niche where few commercial solutions exist. It may also face future competition from other startups and the incumbents' own 3D development efforts.